Immuneering Corporation

NASDAQ: IMRX · Real-Time Price · USD
3.79
0.75 (24.67%)
At close: Aug 15, 2025, 3:59 PM
3.65
-3.57%
After-hours: Aug 15, 2025, 07:49 PM EDT

Immuneering Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a -94.42M -94.42M n/a n/a 94.42M 94.46M 133.25K 316.95K 506.09K 949.84K 1.52M 2.08M 2.56M 2.76M 2.58M
Cost of Revenue
n/a n/a 185.22K 381K 574.51K 764.14K 158.54M 158.37M 158.22M 158.12M 364.34K 564K 835.07K 1.15M 1.42M 1.52M 1.43M
Gross Profit
n/a n/a -94.6M -94.8M -574.51K -764.14K -64.12M -63.91M -158.09M -157.81M 141.75K 385.84K 680.39K 926.58K 1.13M 1.24M 1.14M
Operating Income
-64.23M -64.07M -61.82M -60.47M -59.06M -58.41M -56.1M -55.36M -53.5M -51.74M -48.88M -44.23M -40.58M -33.89M -28.61M -24.46M -20.08M
Interest Income
2.23M 2.59M 2.93M 3.24M 3.58M 3.61M 3.37M 2.74M 1.71M 1.01M 641.17K 435.59K 296.05K 169.9K 27.53K 11.28K 10.49K
Pretax Income
-61.77M -61.04M -58.07M -56.07M -54.18M -53.47M -51.63M -51.88M -51.22M -50.51M -48.36M -44.05M -40.51M -33.84M -28.59M -24.45M -20.07M
Net Income
-61.77M -61.04M -58.07M -56.07M -54.18M 1.02B 1.02B 1.02B 1.03B -49.4M -47.68M -43.71M -40.17M -33.54M -28.59M -24.45M -20.07M
Selling & General & Admin
15.97M 16.08M 16.77M 16.62M 16.41M 16.76M 16.48M 16.45M 16.11M 15.6M 14.64M 13.4M 11.04M 8.27M 6.26M 4.36M 3.65M
Research & Development
48.23M 47.96M 45.02M 43.81M 42.62M 41.62M 39.59M 38.9M 37.43M 36.28M 34.35M 31.2M 30.21M 26.54M 23.48M 21.34M 17.57M
Other Expenses
29.27K 29.27K 486.3K 486.3K 629.18K 629.18K 172.14K 172.14K -2.1K -1.32K -8.63K -24.04K 14.00 -8.09K -8.09K n/a n/a
Operating Expenses
64.23M 64.07M 61.82M 60.47M 59.06M 58.41M 56.1M 55.38M 53.56M 51.9M 49.02M 44.62M 41.26M 34.81M 29.74M 25.7M 21.22M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
64.23M 64.07M 61.82M 60.47M 59.06M 58.41M 56.1M 55.4M 53.63M 52.06M 49.38M 45.18M 42.09M 35.97M 31.16M 27.22M 22.66M
Income Tax Expense
n/a n/a -754.66K -754.66K -1.89M -1.08B -1.08B -1.08B -1.08B -1.17M -733.09K -406.76K -353.57K -324.15K 25.65K 42.63K 42.64K
Shares Outstanding (Basic)
35.53M 31.05M 29.84M 29.65M 29.37M 29.27M 29.27M 28.65M 26.44M 26.41M 26.39M 26.39M 26.36M 25.98M 18.29M 23.89M 13.51M
Shares Outstanding (Diluted)
35.53M 31.05M 29.84M 29.65M 29.37M 29.27M 29.27M 28.65M 26.44M 26.41M 26.39M 26.39M 26.36M 25.98M 18.29M 23.89M 13.51M
EPS (Basic)
-1.96 -2.03 -1.97 -1.91 -1.87 38.78 38.83 38.79 38.78 -1.87 -1.82 -1.82 -1.71 -1.68 -1.69 -1.55 -1.49
EPS (Diluted)
-1.96 -2.03 -1.97 -1.91 -1.87 38.78 38.83 38.79 38.78 -1.87 -1.82 -1.82 -1.71 -1.68 -1.69 -1.55 -1.49
EBITDA
-63.85M -63.69M -60.12M -58.78M -57.39M -56.75M -55.76M -55.03M -53.19M -51.29M -48.43M -43.82M -40.18M -33.68M -28.41M -24.29M -19.93M
EBIT
-64.23M -64.07M -61.82M -60.47M -59.06M -58.33M -56.02M -55.28M -53.42M -51.75M -48.88M -44.23M -40.58M -33.89M -28.56M -24.42M -20.04M
Depreciation & Amortization
380.13K 385.07K 476.86K 576.38K 672.04K 764.14K 768.2K 776.95K 785.8K 796.79K 660.02K 493.05K 325.81K 159.07K 138.78K 117.09K 97.97K